Thank you for visiting our website. The contents on this site have been made available to you to improve medication safety by standardizing concentrations of compounded oral liquids for pediatric patients in the state of Michigan. The concentrations endorsed on this site have been reviewed, approved and endorsed by healthcare providers and safety and healthcare organizations within the state of Michigan. We urge you to consistently use these concentrations as standards in order to promote safety for our patients. Formulation sheets with information on how to compound specific oral liquids may be accessed by clicking on the drug. In rare occurrences, an alternate concentration may be available in addition to the standard; please only utilize the alternate concentration if the patient meets the specific outlined criteria for use. We strongly recommend using commercially manufactured oral products when available. If there are questions or suggestions, please do not hesitate to contact Scott Ciarkowski at ciarkos@med.umich.edu or 734-615-1553.

Thank you for your time and commitment to improving patient safety. 

This research project received financial support from the FDA Safe Use Initiative through the "Novel Interventions and Collaborations to Improve the Safe Use of Medications" grant program. The goal of the Safe Use Initiative is to reduce preventable harm by identifying specific, preventable medication risks and developing, implementing and evaluating cross-sector interventions with partners who are committed to safe medication use. If you would like more information about the Safe Use Initiative, please visit the website at http://www.fda.gov/Drugs/DrugSafety/SafeUseInitiative. The project has also been judged to be exempt by the University of Michigan Institutional Review Board (IRBMED).